BIO-201(BiOneCure Therapeutics)

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameBIO-201(BiOneCure Therapeutics)

Drug Alias NameBIO-201(BiOneCure Therapeutics)BIO-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsDNA topoisomerase I inhibitorsTumor-associated calcium signal transducer 2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2DNA topoisomerase ITumor-associated calcium signal transducer 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiOneCure Biotechnology Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBiOneCure Biotechnology Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A